Koers INVO Bioscience, Inc.
Aandelen
INVO
US44984F4019
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,9801 USD | -16,23% | -35,52% | -27,40% |
Omzet 2024 * | 14,84 mln. 13,87 mln. | Omzet 2025 * | 28,61 mln. 26,74 mln. | Marktkapitalisatie | 3,21 mln. 3 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -4 mln. -3,74 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 0,22 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,11 x |
K/w-verhouding 2024 * |
-4,03
x | K/w-verhouding 2025 * |
-117
x | Werknemers | 28 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,16% |
Recentste transcriptie over INVO Bioscience, Inc.
1 dag | -7,26% | ||
1 week | -29,59% | ||
Lopende maand | -5,28% | ||
1 maand | -6,11% | ||
3 maanden | +0,97% | ||
6 maanden | -33,93% | ||
Lopend jaar | -20,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 11-10-17 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 14-06-21 |
J. Chris Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 16-12-19 |
Barbara Ryan
BRD | Director/Board Member | 64 | 14-09-20 |
Corporate Secretary | 55 | 01-10-08 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 0,9801 | -16,23% | 596 144 |
24-04-24 | 1,17 | -10,00% | 457 087 |
23-04-24 | 1,3 | +4,84% | 610 741 |
22-04-24 | 1,24 | -9,49% | 917 858 |
19-04-24 | 1,37 | -9,87% | 1 395 750 |
uitgestelde koers Nasdaq, 25 april 2024 om 16:10 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,72% | 3,21 mln. | |
-3,48% | 185 mld. | |
-3,98% | 107 mld. | |
-4,98% | 67,55 mld. | |
+8,64% | 54,6 mld. | |
+16,13% | 47,42 mld. | |
+3,86% | 42,24 mld. | |
+6,76% | 28,24 mld. | |
-0,37% | 26,42 mld. | |
+12,40% | 25,66 mld. |